Hipertiroidismo y sistema cardiovascular Bases fisiopatológicas y su ...
Hipertiroidismo y sistema cardiovascular Bases fisiopatológicas y su ...
Hipertiroidismo y sistema cardiovascular Bases fisiopatológicas y su ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INSUFICIENCIA CARDIACA<br />
Vol. 5, Nº 4, 2010<br />
176 D Mantilla y col.<br />
<strong>Hipertiroidismo</strong> y <strong>sistema</strong> <strong>cardiovascular</strong><br />
71. Auer J, Scheibner P, Mische T, et al. Subclinical hyperthyroidism as<br />
a risk factor for atrial fibrillation. Am Heart J 2001;142:838-842.<br />
72. Aras D, Maden O, Ozdemir O, Aras S, Topaloglu S, Yetkin E,<br />
Demir AD, Soylu MO, Erdogan MF, Kisacik HL, Korkmaz<br />
S. Simple electrocardiographic markers for the prediction of<br />
paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol<br />
2005;99(1):59-64.<br />
73. Taeko S, Saori K, Jaduk Y, et al. Hyperthyroidism and the management<br />
of atrial fibrillation. Thyroid 2002;12:489-493.<br />
74. Martin WH III, Spina RJ, Korte E. Effect of hyperthyroidism of<br />
short duration on cardiac sensitivity to beta-adrenergic stimulation.<br />
J Am Coll Cardiol 1992;19:185-191.<br />
75. Forfar J. Atrial fibrillation and the pituitary-thyroid axis: a reevaluation.<br />
Heart 1997;77:3-4.<br />
76. Presti C, Hart R. Thyrotoxicosis, atrial fibrillation, and embolism,<br />
revisited. Am Heart J 1989;273:1057-1061.<br />
77. Loeliger E, Mattern M, Hemker H, et al. The biological disappearance<br />
rate of prothrombin, factors VII, IX and X from plasma in<br />
hypothyroidism, hyperthyroidism, and during fever. Thromb Diath<br />
Haemorrh 1964;10:267-277.<br />
78. Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism<br />
and risk of atrial fibrillation or flutter. Arch Intern Med<br />
2004;164:1675-1678.<br />
79. Falk R. Atrial fibrillation. N Engl J Med 2001;344:1067-1078.<br />
80. Kim D, Smith T. Effects of thyroid hormone on sodium<br />
pump sites, sodium content and contractile responses to cardiac<br />
glycosides in cultured chick ventricular cells. J Clin Invest<br />
1984;74:1481-1488.<br />
Nakazawa K, Sakurai K, Hamada N, Momotani N, Ito K. Manage-<br />
81.<br />
ment of atrial fibrillation in the post-thyrotoxic state. Am J Med<br />
1982;72:903-906.<br />
Nakazawa H, Ishikawa N, Noh J, Sugimoto T, Yoshimoto M,<br />
82.<br />
Yashiro T, Ozaki O, Ito K. Efficacy of disopyramide in conversion<br />
and prophylaxis of post-thyrotoxic atrial fibrillation. Eur J Clin<br />
Pharmacol 1991;40:215-219.<br />
Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger<br />
83.<br />
RW, Black IW, et al. Use of transesophageal echocardiography to<br />
guide cardioversion in patients with atrial fibrillation. N Engl J<br />
Med 2001;344:1411-1420.<br />
84. Klein I. Thyroid hormone and the <strong>cardiovascular</strong> system. Am J<br />
Med 1990;88:631-637.<br />
85. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and heart.<br />
Circulation 1993;87:1453-1441.<br />
86. Bell GM, Sawers SA, Forfar JC, Doig A, Toft D. The effect of<br />
minor increments in plasma thyroxine on heart rate and urinary<br />
sodium excretion. Clin Endocrinol 1983;18:511-516.<br />
Biondi B, Fazio S, Carella C, et al. Cardiac effects of long-term<br />
87.<br />
thyrotropin-<strong>su</strong>ppressive therapy with levothyroxine. J Clin Endocrinol<br />
Metab 1993;77:334-338.<br />
Polikar R, Feld GK, Dittrick FH, Smith J, Nicod P. Effect of thyroid<br />
88.<br />
replacement therapy on the frequency of benign atrial and ventricular<br />
arrhythmias. J Am Coll Card 1989;14:999-1002.<br />
Biondi B, Fazio S, Coltorti F, et al. Reentrant atrioventricular nodal<br />
89.<br />
tachycardia induced by levothyroxine. J Clin Endocrinol Metab<br />
1998;83:2643-2645.<br />
Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard M, Gam-<br />
90.<br />
mage MD. Cardiac hypertrophy as a re<strong>su</strong>lt of long-term thyroxine<br />
therapy and thyrotoxicosis. Heart 1996;75:363-368.<br />
Shapiro LE, Sievert R, Ong L, et al. Minimal cardiac effects<br />
91.<br />
in asymptomatic athyreotic patients chronically treated with<br />
thyrotropin-<strong>su</strong>ppressive doses ofL-thyroxine. J Clin Endocrinol<br />
Metab 1997;82:2592-2595.<br />
Fazio S, Biondi B, Carella C, et al. Diastolic dysfunction in patients<br />
92.<br />
on thyroid-stimulating-hormone <strong>su</strong>ppressive therapy with levothyroxine:<br />
beneficial effect of beta blockade. J Clin Endocrinol Metab<br />
1995;80:2222-2226.<br />
Biondi B, Fazio S, Cuocolo A, et al. Impaired cardiac reserve<br />
93.<br />
and exercise capacity in patients receiving long-term thyrotropin<br />
<strong>su</strong>ppressive therapy with levothyroxine. J Clin Endocrinol Metab<br />
1996;81:4224-4228.<br />
Mercuro G, Panzuto MG, Bina A, et al. Cardiac function, physical<br />
94.<br />
exercise capacity, and quality of life during long-term thyrotropin<strong>su</strong>ppressive<br />
therapy with levothyroxine: effect of individual dose<br />
tailoring. J Clin Endocrinol Metab 2000;85:159-164.<br />
Biondi B, Fazio S, Carella C, et al. Control of adrenergic over<br />
95.<br />
activity by beta-blockade improves the quality of life in patients<br />
receiving long-term <strong>su</strong>ppressive therapy with levothyroxine. J Clin<br />
Endocrinol Metab 1994;78:1028-1033.<br />
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli W.<br />
96.<br />
Prognostic implication of echocardiographically determined left<br />
ventricular mass in the Framingham Heart Study. N Engl J Med<br />
1990;322:1561-1566.<br />
Boutin JM, Matte R, D’Amour P, et al. Characteristic of patients<br />
97.<br />
with normal T3 and T4 and low TSH response to TRH. Clin Endocrinol<br />
1986;25:579-588.<br />
Abe A, Yamamoto T, Isome M, et al. Thyroid hormone regulates<br />
98.<br />
expression of Shaker-related potassium channel mRNA in rat heart.<br />
Biochem Biophys Res Commun 1998;245:226-230.<br />
Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch<br />
99.<br />
Jr HR. Thyroid hormone regulation of beta-adrenergic number. J<br />
Biol Chem 1977;252:2787-2789.<br />
Pachucki J, Burmeister L, Larsen PR. Thyroid hormone regu-<br />
100.<br />
lated hyperpolarization-activated cyclic nucleotide-gated channel<br />
(HCN2) mRNA in the rat heart. Circ Res 1999;85:498-503.<br />
Kannel WB, Kannel C, Paffenbarger Jr RS, Cupples LA. Heart<br />
101.<br />
rate and <strong>cardiovascular</strong> mortality: The Framingham Study. Am<br />
Heart J 1987;113:1489-1494.<br />
Utiger R. Subclinical hyperthyroidism -just a low serum thy-<br />
102.<br />
rotropin concentration, or something more? N Engl J Med<br />
1994;77:332-333.<br />
Benjamín E, Levy D, Vaziri S, et al. Independent risk factors for<br />
103.<br />
atrial fibrillation in a population-based cohort: the Framingham<br />
Heart Study. JAMA 1994;2(71):840-844.<br />
104. Auer J, Berent R, Weber T, Eber B. Hyperthyroidism. Lancet<br />
2003;362:1584.<br />
105. Haissaguerre M, Jais P, Shah D, Takahashi A, Hocini M, Quiniou<br />
G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous<br />
initiation of atrial fibrillation by ectopic beats originating in<br />
the pulmonary veins. N Engl J Med 1998;339:659-666.<br />
Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R,<br />
106.<br />
Beyer J, Meyer J. Cardiac arrhythmias and heart rate in hyperthyroidism.<br />
Am J Cardiol 1989;63:930-933.<br />
Osman F, Daykin J, Sheppard M, Franklyn J, Gammage M. Car-<br />
107.<br />
diac rhythm abnormalities in thyrotoxicosis. The explanation for<br />
excess vascular mortality. J Endocrinol 2000;164:321.<br />
108. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the<br />
heart. Review. Circulation 1993;87:1435-1441.<br />
109. Golf S, Lovstad R, Hansson V. Beta-adrenoceptor density and<br />
relative number of beta-adrenoceptor <strong>su</strong>btypes in biopsies from<br />
human right atrial, left ventricular and right ventricular myocardium.<br />
Cardiovasc Res 1985;19:636-641.<br />
Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I. Regulation<br />
110.<br />
of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid<br />
and chamber specific. Endocrinology 1999;140:3170-3176.<br />
111. Summers V, Surtees S. Thyrotoxicosis and heart disease. Acta<br />
Med Scand 1969;169:661-671.<br />
112. Duan Y, Peng W, Wang X, Tang W, Liu X, Xu S, Mao X, Feng S,<br />
Feng Y, Qin Y, et al. Community-based study of the association<br />
of <strong>su</strong>bclinical thyroid dysfunction with blood pres<strong>su</strong>re. Endocr<br />
2009;35(2):136-142.<br />
113. Nordyke R, Gilbert F, Harada A. Graves’ disease: influence of age<br />
on clinical findings. Arch Intern Med 1988;148:626-631.<br />
114. Pereira N, Parisi A, Dec G, et al. Myocardial stunning in hyperthyroidism.<br />
Clin Cardiol 2000;23:298-300.<br />
115. Marti V, Ballester M, Obrador D, et al. Active myocardial damage<br />
in hyperthyroidism. A concurrent mechanism of heart failure<br />
reversed by treatment. Eur Heart J 1995;16:1014-1016.<br />
Roti E, Montermini M, Roti S, et al. The effect of diltiazem, a<br />
116.<br />
calcium channel blocking drug, on cardiac rate and rhythm in<br />
hyperthyroid patients. Arch Intern Med 1988;148:919-921.<br />
Franklyn J, Maisonneuve P, Sheppard M, Betteridge J, Boyle P.<br />
117.<br />
Mortality after the treatment of hyperthyroidism with radioactive<br />
iodine. N Engl J Med 1998;38:712-718.<br />
118. Woeber K. Update on the management of hyperthyroidism and<br />
hypothyroidism. Arch Intern Med 2000;160:1067-1070.<br />
119. Hasnain M, Khandwala, et al. A case of congestive heart failure<br />
due to reversible dilated cardiomyopathy caused by hyperthyroidism.<br />
Southern Med J 2004;97;10:1001-1003.<br />
Eiffel JA, Estes III NA, Waldo AL, Prystowsky EN, DiBianco<br />
120.<br />
R. A consen<strong>su</strong>s report on antiarrhythmic drug use. Clin Cardiol<br />
1994;17:103-116.<br />
Newnham HH, Topliss DJ, Le Grand BA, Chosich N, Harper RW,<br />
121.<br />
Stockigt JR. Amiodarone-induced hyperthyroidism: assessment of<br />
the predictive value of biochemical testing and response to com-